Scarica l'app Stockscreener
0.462
1.70%
-0.008
Pre-mercato:
.48
0.018
+3.90%
Precedente Chiudi:
$0.47
Aprire:
$0.466
Volume 24 ore:
109.74K
Relative Volume:
0.70
Capitalizzazione di mercato:
$64.80M
Reddito:
$121.91M
Utile/perdita netta:
$1.83M
Rapporto P/E:
42.39
EPS:
0.0109
Flusso di cassa netto:
$7.75M
1 W Prestazione:
-3.75%
1M Prestazione:
-15.18%
6M Prestazione:
-21.73%
1 anno Prestazione:
-33.91%
Intervallo 1D:
$0.462
$0.4799
Intervallo di 1 settimana:
$0.4551
$0.4803
Portata 52W:
$0.438
$0.95
Xtant Medical Holdings Inc Stock (XTNT) Company Profile
Nome
Xtant Medical Holdings Inc
Settore
Industria
Telefono
406-388-0480
Indirizzo
664 Cruiser Lane, Belgrade, MT
Compare XTNT vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XTNT
Xtant Medical Holdings Inc
|
0.462 | 65.92M | 121.91M | 1.83M | 7.75M | 0.0109 |
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
Xtant Medical Holdings Inc Stock (XTNT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-12-05 | Iniziato | BTIG Research | Buy |
| 2018-11-15 | Reiterato | Maxim Group | Buy |
| 2018-02-14 | Reiterato | Maxim Group | Buy |
Xtant Medical Holdings Inc Borsa (XTNT) Ultime notizie
Xtant Medical Holdings (XTNT) Inches Higher as Stock Consolidates Near Key SupportBPI Bull Correction - thelegaladvocate.com
Xtant outlines $95M-$99M 2026 revenue outlook as Companion Spine divestiture and Q-code license revenue roll off - MSN
XTNT Q1 2026 Earnings: EPS Misses Estimates Despite Stock GainCommunity Hot Stocks - Newser
Xtant Medical Holdings Inc. (XTNT) Q1 2026 Earnings: EPS Misses Estimates Amidst Narrow LossSenior Analyst Forecasts - Newser
Xtant Medical Holdings (XTNT) Edges Higher: Testing Key Resistance at $0.50Shared Buy Zones - Newser
Xtant Medical Holdings Holds Near Key Resistance Level After Modest GainCommunity Chart Signals - Newser
Xtant Medical Holdings (XTNT) Gains 2.08% as Stock Approaches Key Resistance at $0.50Profitability Factor - Newser
Xtant Medical Balances New Growth Bets With Near-Term Pain - TipRanks
Xtant Medical launches pre-shaped bone graft product line By Investing.com - Investing.com Nigeria
XTNT SEC FilingsXtant Medical 10-K, 10-Q, 8-K Forms - Stock Titan
Xtant Medical raises FY 2026 revenue guidance to $101M-$105M as it adds HEMOBLAST distribution rights - MSN
Xtant Medical Q1 Earnings Call Highlights - Yahoo Finance
B. Riley Financial | Diversified Financial Services Platform - FinancialContent
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Xtant Medical Holdings’ revenue drops to USD 20.9M in Q1 2026 - Medical Buyer
Xtant Medical Holdings, Inc. (AMEX:XTNT) Q1 2026 Earnings Call Transcript - Insider Monkey
Xtant Medical Holdings, Inc. 2026 Q1 10-Q Report: Financial Results, Strategic Initiatives, and Key Risk Factors - Minichart
Xtant Medical Holdings, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Xtant Medical Boosts 2026 Outlook Amid Tough Quarter - TipRanks
Xtant Medical Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Xtant Medical Holdings Inc Q1 2026 Earnings: Revenue Misses $20.9 million - technotrenz.com
Xtant Medical Q1 2026 Results: Revenue Guidance Raised, Balance Sheet Strengthened, Exclusive HEMOBLAST® Bellows Distribution Secured 12 - Minichart
Xtant Medical Q1 2026 Earnings Call Transcript - MarketBeat
XTNT: Raised 2026 revenue guidance to $101M–$105M amid new product launches and reduced debt - TradingView
Xtant Medical Reports First Quarter 2026 Results and Raises Guidance - HarianBasis.co
Xtant Medical Hldgs Q1 2026 Earnings Call Transcript - Yahoo Finance
Xtant Medical launches Trivium Shaped allograft for surgeries - MSN
Xtant Medical Updates Q1 Results and Raises 2026 Guidance - TipRanks
XTNT: Q1 2026 revenue dropped 37% and net loss reached $3.1M amid asset sales and reimbursement shifts - TradingView
Xtant Medical (XTNT) Q1 2026 revenue drops 37% as divestitures hit sales - Stock Titan
XTNT: Raised 2026 revenue guidance to $101–$105M amid asset sales, new product launches, and debt reduction - TradingView
Xtant Medical (NYSE: XTNT) cuts debt, raises 2026 revenue guidance after Q1 - Stock Titan
Xtant Medical Reports First Quarter 2026 Financial Results - PR Newswire
MSN Money - MSN
TradingKey - TradingKey
Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped - Orthopedics This Week
May 13 before trading: Xtant Medical posts Q1 results, 8:30 ET call - Stock Titan
Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026 - Morningstar
Xtant Medical launches pre-shaped bone graft product line - Investing.com UK
Xtant Medical Holdings Inc Azioni (XTNT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.59%
1.94%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):